药康生物：2025年半年度营业收入同比增长10.11%

Core Insights - The company reported a total operating revenue of 374,808,989.09 yuan for the first half of 2025, reflecting a year-on-year growth of 10.11% [1] - The net profit attributable to shareholders of the listed company was 70,905,477.14 yuan, showing a year-on-year decrease of 7.12% [1] Financial Performance - Operating revenue for the first half of 2025: 374.81 million yuan, up 10.11% compared to the previous year [1] - Net profit for the same period: 70.91 million yuan, down 7.12% year-on-year [1]